Sign in

Neuromyelitis optica (NMOSD) trials, also abroad

78 open Neuromyelitis optica (NMOSD) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
China34
United States18
France10
Germany5
United Kingdom4
Argentina3
Canada2
Japan2
South Korea2
Poland2
United Arab Emirates1
Austria1
Australia1
Brazil1
Switzerland1
Czechia1
Spain1
Greece1
Israel1
Martinique1
Mexico1
Netherlands1
Serbia1
Sweden1
Türkiye1

The same trial often runs in several countries

A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) has 2 sites in Italy and runs in 9 countries. If a site near you is full, another one may still take people.

See A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) in all 9 countries